FGFR4 and neoplasm: Strong FGFR4 immunoreactivity was seen in the cancer cells in 67 of 136 (49%) PDAC samples and high FGFR4 expression correlated with larger primary tumor size and more advanced stages of the cancer (p < 0.001, Table 1).